CD133

CD133 Overview

English NameCD133Approved Drugs0
Drugs in Clinical Trials2Target SynonymAntigen AC133,Prominin-1,PROM1,Prominin 1,Prominin-Like Protein 1,PROML1,Stargardt Disease 4 (Autosomal Dominant),Hematopoietic Stem Cell Antigen,Macular Dystrophy, Retinal 2,Prominin (Mouse)-Like 1,CD133 Antigen,HProminin,MSTP061,CORD12,AC133,CD133,MCDR2,STGD4,RP41,AC133 Antigen
Highest Development StagePhase 2 Clinical
English NameCD133
Target SynonymAntigen AC133,Prominin-1,PROM1,Prominin 1,Prominin-Like Protein 1,PROML1,Stargardt Disease 4 (Autosomal Dominant),Hematopoietic Stem Cell Antigen,Macular Dystrophy, Retinal 2,Prominin (Mouse)-Like 1,CD133 Antigen,HProminin,MSTP061,CORD12,AC133,CD133,MCDR2,STGD4,RP41,AC133 Antigen
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 2 Clinical

CD133 Product List

  • Product Category

    Protein (7)Cell (1)

  • Product Status

    Launched (8)

  • Species

    Human (7)Cynomolgus (1)

  • Tag

    His Tag (3)- (3)His Tag & Avi Tag (1)His Tag & Flag Tag (1)

  • Conjugate

    Unconjugated (4)Biotin-labeled (2)- (1)PE Labeled (1)

CD133 Background

Prominin-1 is also known as CD133, Antigen AC133, PROM1, PROML1 and MSTP061. Is used as marker for hematopoietic stem and progenitor cells (HSPC) for somatic stem cell isolation. May play a role in cell differentiation, proliferation and apoptosis . Binds cholesterol in cholesterol-containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis. Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner.

CD133 Synonyms

CD133,PROM1,PROML1,Prominin-1,AC133

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
P-134P-134; P134Phase 2 ClinicalTianjin Tasly Pharmaceutical Co LtdGlioblastoma
Details
anti-CD133-CAR vector-transduced T cellsPhase 2 ClinicalPla General HospitalBrain Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Liver Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Details
  • Overview
  • Product List
  • Clinical Drug Information